Berbara Helena, Mair Sebastian, Beitz Analena, Henschel Benedikt, Schmid Roland M, Huber Wolfgang
II. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Straße 22, D-81675, München, Germany.
BMC Anesthesiol. 2014 Sep 24;14:81. doi: 10.1186/1471-2253-14-81.
Transpulmonary thermodilution (TPTD) derived parameters are used to direct fluid management in ICU-patients. Extravascular lung water EVLW and its ratio to pulmonary blood volume (pulmonary vascular permeability index PVPI) have been associated with mortality. In single indicator TPTD pulmonary blood volume (PBV) is estimated to be 25% of global end-diastolic volume (GEDV). A recent study demonstrated marked overestimation of GEDV indexed to body-surface area (BSA; GEDVI) when using a femoral central venous catheter (CVC) for indicator injection due to the additional volume measured in the vena cava inferior. Therefore, a correction formula derived from femoral TPTD and biometric data has been suggested. Consequence, one of the commercially available TPTD-devices (PiCCO; Pulsion Medical Systems, Germany) requires information about CVC site. Correction of GEDVI for femoral CVC can be assumed. However, there is no data if correction also pertains to unindexed GEDV, which is used for calculation of PBV and PVPI. Therefore, we investigated, if also GEDV, PBV and PVPI are corrected by the new PiCCO-algorithm.
In this prospective study 110 triplicate TPTDs were performed within 30 hours in 11 adult ICU-patients with PiCCO-monitoring and femoral CVC. We analyzed if the femoral TPTD correction formula for GEDVI was also applied to correct GEDV. Furthermore, we compared PVPIdisplayed to PVPIcalculated which was calculated as EVLWdisplayed/(0.25*GEDVdisplayed).
Multiplication of GEDVIdisplayed by BSA resulted in GEDVcalculated which was not significantly different to GEDVdisplayed (1459 ± 365 mL vs. 1459 ± 366 mL) suggesting that correction for femoral indicator injection also pertains to GEDVdisplayed. However, PVPIdisplayed was significantly lower than PVPIcalculated (1.64 ± 0.57 vs. 2.27 ± 0.72; p < 0.001). In addition to a bias of -0.64 ± 0.22 there was a percentage error of 22%. Application of the correction formula suggested for GEDVI to PVPIdisplayed reduced the bias of PVPIdisplayed compared to EVLW/PBV from -0.64 ± 0.22 to -0.10 ± 0.05 and the percentage error from 22% to 4%.
Correction for femoral CVC in the PiCCO-device pertains to both GEDVIdisplayed and GEDVdisplayed, but not to PVPIdisplayed. To provide consistent information, PVPI should be calculated based on GEDVcorrected in case of femoral CVC.
经肺热稀释(TPTD)衍生参数用于指导重症监护病房(ICU)患者的液体管理。血管外肺水(EVLW)及其与肺血容量的比值(肺血管通透性指数,PVPI)与死亡率相关。在单指标TPTD中,肺血容量(PBV)估计为全心舒张末期容积(GEDV)的25%。最近一项研究表明,当使用股静脉中心静脉导管(CVC)进行指示剂注射时,由于下腔静脉中测量到额外容积,导致以体表面积(BSA;GEDVI)为指标的GEDV被显著高估。因此,有人提出了一种基于股静脉TPTD和生物特征数据的校正公式。结果,一种市售的TPTD设备(PiCCO;德国普升医疗系统公司)需要有关CVC位置的信息。可以假定对股静脉CVC的GEDVI进行校正。然而,尚无数据表明校正是否也适用于未进行指标化的GEDV,而后者用于计算PBV和PVPI。因此,我们研究了新的PiCCO算法是否也对GEDV、PBV和PVPI进行校正。
在这项前瞻性研究中,对11例接受PiCCO监测且有股静脉CVC的成年ICU患者在30小时内进行了110次重复TPTD。我们分析了GEDVI的股静脉TPTD校正公式是否也用于校正GEDV。此外,我们比较了显示的PVPI与计算得到的PVPI,计算得到的PVPI为显示的EVLW/(0.25×显示的GEDV)。
显示的GEDVI乘以BSA得到计算得到的GEDV,其与显示的GEDV无显著差异(1459±365 mL对1459±366 mL),表明对股静脉指示剂注射的校正也适用于显示的GEDV。然而,显示的PVPI显著低于计算得到的PVPI(1.64±0.57对2.27±0.72;p<0.001)。除了-0.64±0.22的偏差外,还有22%的百分比误差。将针对GEDVI建议的校正公式应用于显示的PVPI,与EVLW/PBV相比,显示的PVPI偏差从-0.64±0.22降低至-0.10±0.05,百分比误差从22%降低至4%。
PiCCO设备中对股静脉CVC的校正适用于显示的GEDVI和显示的GEDV,但不适用于显示的PVPI。为提供一致的信息,在股静脉CVC的情况下,PVPI应基于校正后的GEDV进行计算。